Friday, July 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “VENENUM BIODESIGN, LLC”

8 pharma patents match "VENENUM BIODESIGN, LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 8
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 8 pharmaceutical patents matching "VENENUM BIODESIGN, LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

8 results for “VENENUM BIODESIGN, LLC” · 30,257 patents in full index Clear search

  1. US 11883420

    Sting agonists for treating bladder cancer and solid tumors

    VENENUM BIODESIGN, LLC · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  2. US 11583538

    Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors

    VENENUM BIODESIGN, LLC · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted
  3. US 11306098

    Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors

    VENENUM BIODESIGN, LLC · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  4. US 11236055

    Non-systemic TGR5 agonists

    VENENUM BIODESIGN, LLC · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  5. US 11161864

    Sting agonists

    VENENUM BIODESIGN, LLC · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted
  6. US 11110106

    Sting agonists for treating bladder cancer and solid tumors

    VENENUM BIODESIGN, LLC · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  7. US 10669242

    Clostridium difficile toxin inhibitors

    VENENUM BIODESIGN, LLC · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  8. US 10654834

    Non-systemic TGR5 agonists

    VENENUM BIODESIGN, LLC · Granted May 19, 2020 · Expires May 14, 2040

    granted